Neuronetics, Inc. Files 8-K Report
Ticker: STIM · Form: 8-K · Filed: Oct 2, 2024 · CIK: 1227636
| Field | Detail |
|---|---|
| Company | Neuronetics, Inc. (STIM) |
| Form Type | 8-K |
| Filed Date | Oct 2, 2024 |
| Risk Level | low |
| Pages | 9 |
| Reading Time | 10 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, regulatory
Related Tickers: NRTX
TL;DR
Neuronetics filed an 8-K, likely containing important updates for investors.
AI Summary
On October 2, 2024, Neuronetics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Neuronetics, Inc. is providing updates or disclosures to the SEC, which could contain important information for investors regarding the company's financial status or regulatory compliance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and the provided excerpt does not contain information indicating significant risk.
Key Players & Entities
- Neuronetics, Inc. (company) — Registrant
- October 2, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Malvern, PA (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Neuronetics, Inc.?
The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is October 2, 2024.
In which state is Neuronetics, Inc. incorporated?
Neuronetics, Inc. is incorporated in Delaware.
What is the address of Neuronetics, Inc.'s principal executive offices?
The address is 3222 Phoenixville Pike, Malvern, PA 19355.
What is the Commission File Number for Neuronetics, Inc.?
The Commission File Number is 001-38546.
Filing Stats: 2,581 words · 10 min read · ~9 pages · Grade level 17.2 · Accepted 2024-10-02 16:34:05
Key Financial Figures
- $0.01 — ange on which registered Common Stock ($0.01 par value) STIM The Nasdaq Global M
Filing Documents
- d878395d8k.htm (8-K) — 56KB
- d878395dex991.htm (EX-99.1) — 36KB
- g878395ex99_1p10g1.jpg (GRAPHIC) — 248KB
- g878395ex99_1p11g1.jpg (GRAPHIC) — 268KB
- g878395ex99_1p12g1.jpg (GRAPHIC) — 293KB
- g878395ex99_1p13g1.jpg (GRAPHIC) — 223KB
- g878395ex99_1p14g1.jpg (GRAPHIC) — 181KB
- g878395ex99_1p15g1.jpg (GRAPHIC) — 321KB
- g878395ex99_1p16g1.jpg (GRAPHIC) — 205KB
- g878395ex99_1p17g1.jpg (GRAPHIC) — 279KB
- g878395ex99_1p18g1.jpg (GRAPHIC) — 243KB
- g878395ex99_1p19g1.jpg (GRAPHIC) — 175KB
- g878395ex99_1p1g1.jpg (GRAPHIC) — 145KB
- g878395ex99_1p20g1.jpg (GRAPHIC) — 72KB
- g878395ex99_1p21g1.jpg (GRAPHIC) — 236KB
- g878395ex99_1p22g1.jpg (GRAPHIC) — 104KB
- g878395ex99_1p2g1.jpg (GRAPHIC) — 512KB
- g878395ex99_1p3g1.jpg (GRAPHIC) — 487KB
- g878395ex99_1p4g1.jpg (GRAPHIC) — 645KB
- g878395ex99_1p5g1.jpg (GRAPHIC) — 367KB
- g878395ex99_1p6g1.jpg (GRAPHIC) — 245KB
- g878395ex99_1p7g1.jpg (GRAPHIC) — 247KB
- g878395ex99_1p8g1.jpg (GRAPHIC) — 284KB
- g878395ex99_1p9g1.jpg (GRAPHIC) — 395KB
- 0001193125-24-231186.txt ( ) — 8736KB
- stim-20241002.xsd (EX-101.SCH) — 3KB
- stim-20241002_lab.xml (EX-101.LAB) — 17KB
- stim-20241002_pre.xml (EX-101.PRE) — 11KB
- d878395d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit 99.1 Understanding the Benefits of Neuronetics' Greenbrook Acquisition 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 2, 2024 NEURONETICS, INC. By: /s/ W. Andrew Macan W. Andrew Macan EVP, GC & Chief Compliance Officer 3